Dr Anna Kydd graduated from the University of Birmingham in 2003. She completed her general medical training in Birmingham and her cardiology subspecialty training in Cambridge at Addenbrooke’s and Papworth Hospitals. She was awarded a Doctorate of Medicine (MD) from the University of Cambridge in 2016 following a period of research into the role of echocardiography in guiding cardiac resynchronisation therapy for patients with heart failure. She completed a fellowship in cardiac MRI in London at the Heart Hospital and Barts Hospital. Her areas of interest are advanced heart failure, heart transplantation and mechanical circulatory support and cardiac imaging. She has obtained European Society of Cardiology Cardiac Magnetic Resonance Accreditation to level 3 and British society of Echocardiography accreditation in transthoracic and transoesophageal echocardiography.
Dr Kydd was appointed a Consultant Cardiologist at Papworth in 2016. She works as part of a multi-disciplinary team looking after patients with advanced heart failure, patients who have undergone heart transplant and patients who are supported with ventricular assist devices.
Advanced Heart Failure, Mechanical Circulatory Support, Cardiac Transplantation, Cardiac MRI
Heart Transplantation, Cardiac Imaging
BMedSc (Physiology) University of Birmingham 2000
MBChB with Honours University of Birmingham 2003
MRCP (UK) 2006
British Society of Echocardiography Transthoracic Echocardiography Accreditation 2010
British Society of Echocardiography Transoesophageal Echocardiography Accreditation 2013
European Society of Cardiology Cardiac Magnetic Resonance Level 3 Accreditation 2015
Doctorate of Medicine (MD) University of Cambridge 2016
Member of the Royal College of Physicians of London
Member of the British Cardiovascular Society
Member of the International Society for Heart and Lung Transplantation
Member of the European Association of Cardiovascular Imaging
Member of the Heart Failure Association of the European Society of Cardiology
Ali JM, Vuylsteke A, Fowles JA, Pettit S, Salaunkey K, Bhagra S, Lewis C, Parameshwar J, Kydd A, Patvardhan C, Jones N, Rubino A, Abu-Omar Y, Sudarshan C, Tsui S, Catarino P, Jenkins DP, Berman M. Transfer of Patients With Cardiogenic Shock Using Veno-Arterial Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth. 2019 May 16. [Epub ahead of print]
Clarke SJ, Pettit S, Giblett JP, Zhao T, Kydd AC, Albrechtsen NJW, Deacon CF, Parameshwar J, Hoole SP. Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study. Clin Ther. 2019 Jan;41(1):118-127.
Messer S, Page A, Axell R, Berman M, Hernández-Sánchez J, Colah S, Parizkova B, Valchanov K, Dunning J, Pavlushkov E, Balasubramanian SK, Parameshwar J, Omar YA, Goddard M, Pettit S, Lewis C, Kydd A, Jenkins D, Watson CJ, Sudarshan C, Catarino P, Findlay M, Ali A, Tsui S, Large SR. Outcome after heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2017 Dec;36(12):1311-1318.
Sabzevari K, Oldman J, Herrey AS, Moon JC, Kydd AC, Manisty C. Provision of magnetic resonance imaging for patients with 'MR-conditional' cardiac implantable electronic devices: an unmet clinical need. Europace. 2017 Mar 1;19(3):425-431.
McCormick LM, Heck PM, Ring LS, Kydd AC, Clarke SJ, Hoole SP, Dutka DP. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2015 Aug 8;14:102. doi: 10.1186/s12933-015-0259-3.
Kydd AC, McNab D, Calvert PA, Hoole SP, Rekhraj S, Sievert H, Shapiro LM, Rana BS. The Eustachian ridge: not an innocent bystander. JACC Cardiovasc Imaging. 2014 Oct;7(10):1062-3.
Kydd AC, Khan FZ, Ring L, Pugh PJ, Virdee MS, Dutka DP. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy. Eur J Heart Fail. 2014 Nov;16(11):1206-13.
Kydd AC, Khan FZ, Watson WD, Pugh PJ, Virdee MS, Dutka DP. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort. JACC Heart Fail. 2014 Jun;2(3):205-12.
Ring L, Rana BS, Wells FC, Kydd AC, Dutka DP. Atrial function as a guide to timing of intervention in mitral valve prolapse with mitral regurgitation. JACC Cardiovasc Imaging. 2014 Mar;7(3):225-32.
McCormick LM, Kydd AC, Read PA, Ring LS, Bond SJ, Hoole SP, Dutka DP. Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease. Circ Cardiovasc Imaging. 2014 Mar;7(2):274-81.
Kydd AC, Khan F, Gopalan D, Ring L, Rana BS, Virdee MS, Dutka DP. Utility of speckle tracking echocardiography to characterize dysfunctional myocardium in patients with ischemic cardiomyopathy referred for cardiac resynchronization therapy. Echocardiography. 2014 Jul;31(6):736-43.
Contact details:
SwitchBoard: 01223 638000
Secretary
Joanna Turnbull
Telephone: 01223 639512
Email: joanna.turnbull@nhs.net